ABT vs VSTD · P/E 25, rev $44.33B vs rev $12.8M
Abbott Laboratories (ABT) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the ABT and VSTD stock pages for the full models.
Not investment advice.